Kyle Guse

Insider Reports History

Entity
Individual
Location
C/O Atossa Genetics Inc., 1616 Eastlake Ave. E Suite 510, Seattle, WA
Signature
/s/ Kyle Guse
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kyle Guse:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ATOSSA THERAPEUTICS, INC. CFO, Gen Counsel and Secretary Stock Option (right to buy) 558K Mar 2, 2023 Direct

Insider Reports Filed by Kyle Guse

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATOS ATOSSA THERAPEUTICS, INC. Mar 2, 2023 1 $0 4 Mar 6, 2023 CFO, Gen Counsel and Secretary
ATOS ATOSSA THERAPEUTICS, INC. Feb 24, 2022 1 $0 4 Feb 28, 2022 CFO, Gen Counsel and Secretary
ATOS ATOSSA THERAPEUTICS, INC. May 14, 2021 1 $0 4 May 18, 2021 CFO, Gen Counsel and Secretary